SEC Form 4 filed by Director Kennedy Kevin

$ULS
Precision Instruments
Health Care
Get the next $ULS alert in real time by email
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KENNEDY KEVIN

(Last) (First) (Middle)
C/O UL SOLUTIONS INC.
333 PFINGSTEN ROAD

(Street)
NORTHBROOK IL 60062

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UL Solutions Inc. [ ULS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Dividend Equivalent Rights (1) 03/10/2025 A 12 (2) (2) Class A Common Stock 12 $0 49 D
Explanation of Responses:
1. Each dividend equivalent right is the economic equivalent of one share of the Issuer's Class A Common Stock.
2. The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate.
/s/ Ryan Robinson, Attorney-in-Fact 03/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Get the next $ULS alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ULS

DatePrice TargetRatingAnalyst
10/7/2024$60.00Buy
Citigroup
7/12/2024$41.00 → $46.00Outperform → Neutral
Robert W. Baird
More analyst ratings

$ULS
Press Releases

Fastest customizable press release news feed in the world

See more
  • Evnia Announces Strategic Partnership With UL Solutions

    MONTREAL, March 19, 2025 /PRNewswire/ - Evnia, a leader in environmental compliance and ecofee management, is proud to announce its strategic partnership with UL Solutions, a global leader in applied safety science. This partnership aims to provide companies with optimized solutions for managing their regulatory obligations related to Extended Producer Responsibility (EPR) and environmental compliance. "At Evnia, our mission is to simplify ecofee management for our clients. This partnership with UL Solutions allows us to take a step further toward excellence by offering in-depth technical expertise combined with a global perspective on environmental challenges, especially for U.S.-based com

    $ULS
    Precision Instruments
    Health Care
  • UL Solutions Inc. Files Lawsuit Against Fly-E Group, Inc. to Protect Trusted Safety Mark

    The electric vehicle company and its subsidiaries are accused of counterfeiting, federal trademark infringement and deceptive business practices UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, has filed a lawsuit against Fly-E Group, Inc. (NYSE:FLYE), its subsidiaries – including Fly E-Bike, FlyBwy, and FlyCycle – and several executives for allegedly counterfeiting the UL Mark to falsely advertise their entire line of e-bikes, e-scooters and e-motorcycles as UL Certified when they did not undergo the company's product testing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250313314816/en/Example of the

    $FLYE
    $ULS
    Aerospace
    Industrials
    Precision Instruments
    Health Care
  • UL Solutions Inc. Names New Chief Legal Officer

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it appointed Scott D'Angelo as executive vice president and chief legal officer, effective April 21, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250311928632/en/UL Solutions names Scott D'Angelo as executive vice president and chief legal officer (Photo: Business Wire) D'Angelo's appointment fills a vacant role and he joins the company's executive leadership team, reporting to President and CEO Jennifer Scanlon. D'Angelo will oversee the legal, brand integrity, ethics and compliance functions. He most recently served as vice presiden

    $ULS
    Precision Instruments
    Health Care

$ULS
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$ULS
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$ULS
SEC Filings

See more

$ULS
Leadership Updates

Live Leadership Updates

See more
  • UL Solutions Inc. Names New Chief Legal Officer

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it appointed Scott D'Angelo as executive vice president and chief legal officer, effective April 21, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250311928632/en/UL Solutions names Scott D'Angelo as executive vice president and chief legal officer (Photo: Business Wire) D'Angelo's appointment fills a vacant role and he joins the company's executive leadership team, reporting to President and CEO Jennifer Scanlon. D'Angelo will oversee the legal, brand integrity, ethics and compliance functions. He most recently served as vice presiden

    $ULS
    Precision Instruments
    Health Care
  • UL Solutions Names Chief Business Operations and Innovation Officer

    Alex Dadakis to join UL Solutions leadership team in newly created role UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it appointed Alex Dadakis as Executive Vice President, Chief Business Operations and Innovation Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241205299962/en/UL Solutions announced the appointment of Alex Dadakis as Executive Vice President, Chief Business Operations and Innovation Officer, effective Jan. 27, 2025. (Photo: Business Wire) Dadakis, who most recently served as Senior Vice President, Global Head of Strategy and Corporate Development at Germany-ba

    $ULS
    Precision Instruments
    Health Care
  • UL Solutions Acquires Germany-Based Battery Testing and Simulation Company BatterieIngenieure

    Deal deepens UL Solutions' global expertise in battery performance testing and expands our global EV battery testing footprint. UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced our acquisition of BatterieIngenieure GmbH, a battery testing company based in Aachen, Germany, with expertise in specialized performance testing of cell, small modules and battery systems used in electric vehicles and other applications. The acquisition augments UL Solutions' global battery testing footprint with a laboratory in Europe. BatterieIngenieure provides comprehensive testing, simulation and failure analysis of battery technologies, with distinctive expertise in

    $ULS
    Precision Instruments
    Health Care

$ULS
Financials

Live finance-specific insights

See more
  • UL Solutions Announces Increased Quarterly Dividend

    UL Solutions Inc. (NYSE:ULS), a global safety science leader, today announced that its board of directors has declared a quarterly dividend of $0.13 per share, an increase of $0.005 per share, bringing the annual dividend rate to $0.52 per share, up 4% from the previous annual rate. The dividend will be paid on March 10, 2025, to shareholders of record as of the close of business on Feb. 28, 2025. "UL Solutions is pleased to increase our quarterly dividend and provide this additional return to shareholders," said Jennifer Scanlon, president and CEO. About UL Solutions A global leader in applied safety science, UL Solutions Inc. transforms safety, security and sustainability challenges

    $ULS
    Precision Instruments
    Health Care
  • UL Solutions Inc. Sets Date for Fourth Quarter and Full Year 2024 Results

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it will release financial results for the fourth quarter and full year 2024 before the market opens on Thursday, February 20. Management will host a webcast and conference call that same day at 8:30 a.m. EST (7:30 a.m. CST) to review results. Webcast and Conference Call The conference call will be broadcast live over the Internet. Additionally, a slide presentation will accompany the conference call. To listen to the call and view the slides, please visit the Investors section of UL Solutions' website at www.ul.com. For those who are unable to listen to the live broadcast, an audio replay of the con

    $ULS
    Precision Instruments
    Health Care
  • UL Solutions Announces Quarterly Dividend

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced that its Board of Directors has declared a quarterly dividend of $0.125 per share. The dividend will be paid on December 9, 2024, to shareholders of record as of the close of business on November 29, 2024. About UL Solutions A global leader in applied safety science, UL Solutions Inc. transforms safety, security and sustainability challenges into opportunities for customers in more than 110 countries. UL Solutions Inc. delivers testing, inspection and certification services together with software products and advisory offerings that support our customers' product innovation and business growth. The

    $ULS
    Precision Instruments
    Health Care

$ULS
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more